67389-47-3

Basic information

• Product Name: D-Serine, N-[(1,1-dimethylethoxy)carbonyl]-O-(phenylmethyl)-, methyl ester
• CAS NO: 67389-47-3
• Molecular Formula: C16H23NO5
• Molecular Weight: 309.362
• Mol File: 67389-47-3.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: D-Serine, N-[(1,1-dimethylethoxy)carbonyl]-O-(phenylmethyl)-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: D-Serine, N-[(1,1-dimethylethoxy)carbonyl]-O-(phenylmethyl)-, methyl ester(67389-47-3)
• EPA Substance Registry System: D-Serine, N-[(1,1-dimethylethoxy)carbonyl]-O-(phenylmethyl)-, methyl ester(67389-47-3)

Safety Data

• Hazardous Substances Data: 67389-47-3(Hazardous Substances Data)

Upstream product

• 47173-80-8 N-Boc-D-serine(Bzl)-OH 
• 18107-18-1 diazomethyl-trimethyl-silane 
• 80-11-5 N-methyl-N-nitrosotoluene-p-sulfonamide 
• 74-88-4 methyl iodide 

Downstream Products

• 84907-81-3 (2R)-3-benzyloxy-2-aminopropanoic acid methyl ester 
• 350685-50-6 tert-butyl (R)-(1-(benzyloxy)-3-oxopropan-2-yl)carbamate 
• 752251-06-2 (S)-3-amino-6,7-bis(OBn)-1,1-dimethyl-1,2,3,4-tetrahydroquinolin-1-ium L-ser(OBn)-D-ser (OBn)-BocL-thr(OBn) 
• 752251-07-3 H-L-Thr(OBn)-D-Ser(OBn)-LSer(OBn)-(3S)-THQ(OBn) 
• 752251-20-0 (2R)-3-benzyloxy-2-((2S)-3-benzyloxy-2-tert-butoxycarbonylamino-butyrylamino)propionic acid 
• 752251-21-1 (2R)-3-benzyloxy-2-((2S)-3-benzyloxy-2-tert-butoxycarbonylamino-butyrylamino)propionic acid methyl ester 
• 79069-15-1 tert-butyl N-[(1S)-1-(benzyloxymethyl)-2-hydroxy-ethyl]carbamate 

Relevant articles and documents

Total synthesis of (-)-aplaminal

(Chemical Equation Presented) The total synthesis and assignment of absolute configuration of (-)-aplaminal (1), a cytotoxic metabolite from a sea hare possessing a triazobicyclo[3.2.1]octane skeleton, has been achieved. The synthesis entailed condensatio

Combinations of β3 agonists and growth hormone secretagogues

This invention is directed to pharmaceutical compositions comprising β3adrenergic agonists including (4-(2-(2-(6-aminopyridin-3-yl)-2(R)-hydroxyethylamino)ethoxy)phenyl)acetic acid and growth hormone or growth hormone secretagogues, prodrugs thereof or pharmaceutically acceptable salts of said compounds or said prodrugs. The invention is also directed to methods of using those compositions in the treatment of obesity, diabetes, hypertension and frailty in animals and particularly in humans.

Synthesis of an enantiomerically pure serine-derived thiazole

Previously reported methods for preparing enantiomerically pure thiazoles are inadequate for the synthesis of inherently labile O-alkyl serine-derived thiazoles. The intermediate N-Boc-(O-methylseryl) thiazolines are very susceptible to tautomerization, e